English
简体中文
Total: £ 56.28
Published Date: 2025-04-10 | Pages: 95 | Tables: 96 | Pharma & Healthcare
The global market for Sepsis Treatment was valued at US$ 3814 million in the year 2024 and is projected to reach a revised size of US$ 5967 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.
Market competition is intense. Pfizer, NCPC, Bayer, Shanghai Pharmaceuticals, Johnson & Johnson, Novartis, GlaxoSmithKline etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry. Pfizer accounted for largest market share of about 3% in 2019.
This report aims to provide a comprehensive presentation of the global market for Sepsis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sepsis Treatment.
The Sepsis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sepsis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sepsis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
NCPC
Bayer
Shanghai Pharmaceuticals
Johnson & Johnson
Novartis
GlaxoSmithKline
TEVA
Mylan
Allergan
Merck & Co
Asahi Kasei Corporation
AtoxBio
INOTREM
Adrenomed
Endacea
Segment by Type
Cephalosporin
Pencillin
Macrolides
Others
Segment by Application
Sepsis
Severe Sepsis
Septic Shock
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sepsis Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sepsis Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cephalosporin
1.2.3 Pencillin
1.2.4 Macrolides
1.2.5 Others
1.3 Market by Application
1.3.1 Global Sepsis Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Sepsis
1.3.3 Severe Sepsis
1.3.4 Septic Shock
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sepsis Treatment Market Perspective (2020-2031)
2.2 Global Sepsis Treatment Growth Trends by Region
2.2.1 Global Sepsis Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Sepsis Treatment Historic Market Size by Region (2020-2025)
2.2.3 Sepsis Treatment Forecasted Market Size by Region (2026-2031)
2.3 Sepsis Treatment Market Dynamics
2.3.1 Sepsis Treatment Industry Trends
2.3.2 Sepsis Treatment Market Drivers
2.3.3 Sepsis Treatment Market Challenges
2.3.4 Sepsis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sepsis Treatment Players by Revenue
3.1.1 Global Top Sepsis Treatment Players by Revenue (2020-2025)
3.1.2 Global Sepsis Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Sepsis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Sepsis Treatment Revenue
3.4 Global Sepsis Treatment Market Concentration Ratio
3.4.1 Global Sepsis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sepsis Treatment Revenue in 2024
3.5 Global Key Players of Sepsis Treatment Head office and Area Served
3.6 Global Key Players of Sepsis Treatment, Product and Application
3.7 Global Key Players of Sepsis Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sepsis Treatment Breakdown Data by Type
4.1 Global Sepsis Treatment Historic Market Size by Type (2020-2025)
4.2 Global Sepsis Treatment Forecasted Market Size by Type (2026-2031)
5 Sepsis Treatment Breakdown Data by Application
5.1 Global Sepsis Treatment Historic Market Size by Application (2020-2025)
5.2 Global Sepsis Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Sepsis Treatment Market Size (2020-2031)
6.2 North America Sepsis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Sepsis Treatment Market Size by Country (2020-2025)
6.4 North America Sepsis Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sepsis Treatment Market Size (2020-2031)
7.2 Europe Sepsis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Sepsis Treatment Market Size by Country (2020-2025)
7.4 Europe Sepsis Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sepsis Treatment Market Size (2020-2031)
8.2 Asia-Pacific Sepsis Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Sepsis Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Sepsis Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sepsis Treatment Market Size (2020-2031)
9.2 Latin America Sepsis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Sepsis Treatment Market Size by Country (2020-2025)
9.4 Latin America Sepsis Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sepsis Treatment Market Size (2020-2031)
10.2 Middle East & Africa Sepsis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Sepsis Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Sepsis Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Sepsis Treatment Introduction
11.1.4 Pfizer Revenue in Sepsis Treatment Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 NCPC
11.2.1 NCPC Company Details
11.2.2 NCPC Business Overview
11.2.3 NCPC Sepsis Treatment Introduction
11.2.4 NCPC Revenue in Sepsis Treatment Business (2020-2025)
11.2.5 NCPC Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Sepsis Treatment Introduction
11.3.4 Bayer Revenue in Sepsis Treatment Business (2020-2025)
11.3.5 Bayer Recent Development
11.4 Shanghai Pharmaceuticals
11.4.1 Shanghai Pharmaceuticals Company Details
11.4.2 Shanghai Pharmaceuticals Business Overview
11.4.3 Shanghai Pharmaceuticals Sepsis Treatment Introduction
11.4.4 Shanghai Pharmaceuticals Revenue in Sepsis Treatment Business (2020-2025)
11.4.5 Shanghai Pharmaceuticals Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Sepsis Treatment Introduction
11.5.4 Johnson & Johnson Revenue in Sepsis Treatment Business (2020-2025)
11.5.5 Johnson & Johnson Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Sepsis Treatment Introduction
11.6.4 Novartis Revenue in Sepsis Treatment Business (2020-2025)
11.6.5 Novartis Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Sepsis Treatment Introduction
11.7.4 GlaxoSmithKline Revenue in Sepsis Treatment Business (2020-2025)
11.7.5 GlaxoSmithKline Recent Development
11.8 TEVA
11.8.1 TEVA Company Details
11.8.2 TEVA Business Overview
11.8.3 TEVA Sepsis Treatment Introduction
11.8.4 TEVA Revenue in Sepsis Treatment Business (2020-2025)
11.8.5 TEVA Recent Development
11.9 Mylan
11.9.1 Mylan Company Details
11.9.2 Mylan Business Overview
11.9.3 Mylan Sepsis Treatment Introduction
11.9.4 Mylan Revenue in Sepsis Treatment Business (2020-2025)
11.9.5 Mylan Recent Development
11.10 Allergan
11.10.1 Allergan Company Details
11.10.2 Allergan Business Overview
11.10.3 Allergan Sepsis Treatment Introduction
11.10.4 Allergan Revenue in Sepsis Treatment Business (2020-2025)
11.10.5 Allergan Recent Development
11.11 Merck & Co
11.11.1 Merck & Co Company Details
11.11.2 Merck & Co Business Overview
11.11.3 Merck & Co Sepsis Treatment Introduction
11.11.4 Merck & Co Revenue in Sepsis Treatment Business (2020-2025)
11.11.5 Merck & Co Recent Development
11.12 Asahi Kasei Corporation
11.12.1 Asahi Kasei Corporation Company Details
11.12.2 Asahi Kasei Corporation Business Overview
11.12.3 Asahi Kasei Corporation Sepsis Treatment Introduction
11.12.4 Asahi Kasei Corporation Revenue in Sepsis Treatment Business (2020-2025)
11.12.5 Asahi Kasei Corporation Recent Development
11.13 AtoxBio
11.13.1 AtoxBio Company Details
11.13.2 AtoxBio Business Overview
11.13.3 AtoxBio Sepsis Treatment Introduction
11.13.4 AtoxBio Revenue in Sepsis Treatment Business (2020-2025)
11.13.5 AtoxBio Recent Development
11.14 INOTREM
11.14.1 INOTREM Company Details
11.14.2 INOTREM Business Overview
11.14.3 INOTREM Sepsis Treatment Introduction
11.14.4 INOTREM Revenue in Sepsis Treatment Business (2020-2025)
11.14.5 INOTREM Recent Development
11.15 Adrenomed
11.15.1 Adrenomed Company Details
11.15.2 Adrenomed Business Overview
11.15.3 Adrenomed Sepsis Treatment Introduction
11.15.4 Adrenomed Revenue in Sepsis Treatment Business (2020-2025)
11.15.5 Adrenomed Recent Development
11.16 Endacea
11.16.1 Endacea Company Details
11.16.2 Endacea Business Overview
11.16.3 Endacea Sepsis Treatment Introduction
11.16.4 Endacea Revenue in Sepsis Treatment Business (2020-2025)
11.16.5 Endacea Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Sepsis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cephalosporin
Table 3. Key Players of Pencillin
Table 4. Key Players of Macrolides
Table 5. Key Players of Others
Table 6. Global Sepsis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Sepsis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Sepsis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Sepsis Treatment Market Share by Region (2020-2025)
Table 10. Global Sepsis Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Sepsis Treatment Market Share by Region (2026-2031)
Table 12. Sepsis Treatment Market Trends
Table 13. Sepsis Treatment Market Drivers
Table 14. Sepsis Treatment Market Challenges
Table 15. Sepsis Treatment Market Restraints
Table 16. Global Sepsis Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Sepsis Treatment Market Share by Players (2020-2025)
Table 18. Global Top Sepsis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Treatment as of 2024)
Table 19. Ranking of Global Top Sepsis Treatment Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Sepsis Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Sepsis Treatment, Headquarters and Area Served
Table 22. Global Key Players of Sepsis Treatment, Product and Application
Table 23. Global Key Players of Sepsis Treatment, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Sepsis Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Sepsis Treatment Revenue Market Share by Type (2020-2025)
Table 27. Global Sepsis Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Sepsis Treatment Revenue Market Share by Type (2026-2031)
Table 29. Global Sepsis Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Sepsis Treatment Revenue Market Share by Application (2020-2025)
Table 31. Global Sepsis Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Sepsis Treatment Revenue Market Share by Application (2026-2031)
Table 33. North America Sepsis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Sepsis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Sepsis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Sepsis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Sepsis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Sepsis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Sepsis Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Sepsis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Sepsis Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Sepsis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Sepsis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Sepsis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Sepsis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Sepsis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Sepsis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. Pfizer Company Details
Table 49. Pfizer Business Overview
Table 50. Pfizer Sepsis Treatment Product
Table 51. Pfizer Revenue in Sepsis Treatment Business (2020-2025) & (US$ Million)
Table 52. Pfizer Recent Development
Table 53. NCPC Company Details
Table 54. NCPC Business Overview
Table 55. NCPC Sepsis Treatment Product
Table 56. NCPC Revenue in Sepsis Treatment Business (2020-2025) & (US$ Million)
Table 57. NCPC Recent Development
Table 58. Bayer Company Details
Table 59. Bayer Business Overview
Table 60. Bayer Sepsis Treatment Product
Table 61. Bayer Revenue in Sepsis Treatment Business (2020-2025) & (US$ Million)
Table 62. Bayer Recent Development
Table 63. Shanghai Pharmaceuticals Company Details
Table 64. Shanghai Pharmaceuticals Business Overview
Table 65. Shanghai Pharmaceuticals Sepsis Treatment Product
Table 66. Shanghai Pharmaceuticals Revenue in Sepsis Treatment Business (2020-2025) & (US$ Million)
Table 67. Shanghai Pharmaceuticals Recent Development
Table 68. Johnson & Johnson Company Details
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Sepsis Treatment Product
Table 71. Johnson & Johnson Revenue in Sepsis Treatment Business (2020-2025) & (US$ Million)
Table 72. Johnson & Johnson Recent Development
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Sepsis Treatment Product
Table 76. Novartis Revenue in Sepsis Treatment Business (2020-2025) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. GlaxoSmithKline Company Details
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Sepsis Treatment Product
Table 81. GlaxoSmithKline Revenue in Sepsis Treatment Business (2020-2025) & (US$ Million)
Table 82. GlaxoSmithKline Recent Development
Table 83. TEVA Company Details
Table 84. TEVA Business Overview
Table 85. TEVA Sepsis Treatment Product
Table 86. TEVA Revenue in Sepsis Treatment Business (2020-2025) & (US$ Million)
Table 87. TEVA Recent Development
Table 88. Mylan Company Details
Table 89. Mylan Business Overview
Table 90. Mylan Sepsis Treatment Product
Table 91. Mylan Revenue in Sepsis Treatment Business (2020-2025) & (US$ Million)
Table 92. Mylan Recent Development
Table 93. Allergan Company Details
Table 94. Allergan Business Overview
Table 95. Allergan Sepsis Treatment Product
Table 96. Allergan Revenue in Sepsis Treatment Business (2020-2025) & (US$ Million)
Table 97. Allergan Recent Development
Table 98. Merck & Co Company Details
Table 99. Merck & Co Business Overview
Table 100. Merck & Co Sepsis Treatment Product
Table 101. Merck & Co Revenue in Sepsis Treatment Business (2020-2025) & (US$ Million)
Table 102. Merck & Co Recent Development
Table 103. Asahi Kasei Corporation Company Details
Table 104. Asahi Kasei Corporation Business Overview
Table 105. Asahi Kasei Corporation Sepsis Treatment Product
Table 106. Asahi Kasei Corporation Revenue in Sepsis Treatment Business (2020-2025) & (US$ Million)
Table 107. Asahi Kasei Corporation Recent Development
Table 108. AtoxBio Company Details
Table 109. AtoxBio Business Overview
Table 110. AtoxBio Sepsis Treatment Product
Table 111. AtoxBio Revenue in Sepsis Treatment Business (2020-2025) & (US$ Million)
Table 112. AtoxBio Recent Development
Table 113. INOTREM Company Details
Table 114. INOTREM Business Overview
Table 115. INOTREM Sepsis Treatment Product
Table 116. INOTREM Revenue in Sepsis Treatment Business (2020-2025) & (US$ Million)
Table 117. INOTREM Recent Development
Table 118. Adrenomed Company Details
Table 119. Adrenomed Business Overview
Table 120. Adrenomed Sepsis Treatment Product
Table 121. Adrenomed Revenue in Sepsis Treatment Business (2020-2025) & (US$ Million)
Table 122. Adrenomed Recent Development
Table 123. Endacea Company Details
Table 124. Endacea Business Overview
Table 125. Endacea Sepsis Treatment Product
Table 126. Endacea Revenue in Sepsis Treatment Business (2020-2025) & (US$ Million)
Table 127. Endacea Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Sepsis Treatment Picture
Figure 2. Global Sepsis Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sepsis Treatment Market Share by Type: 2024 VS 2031
Figure 4. Cephalosporin Features
Figure 5. Pencillin Features
Figure 6. Macrolides Features
Figure 7. Others Features
Figure 8. Global Sepsis Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Sepsis Treatment Market Share by Application: 2024 VS 2031
Figure 10. Sepsis Case Studies
Figure 11. Severe Sepsis Case Studies
Figure 12. Septic Shock Case Studies
Figure 13. Sepsis Treatment Report Years Considered
Figure 14. Global Sepsis Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Sepsis Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Sepsis Treatment Market Share by Region: 2024 VS 2031
Figure 17. Global Sepsis Treatment Market Share by Players in 2024
Figure 18. Global Top Sepsis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Treatment as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Sepsis Treatment Revenue in 2024
Figure 20. North America Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Sepsis Treatment Market Share by Country (2020-2031)
Figure 22. United States Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Sepsis Treatment Market Share by Country (2020-2031)
Figure 26. Germany Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Sepsis Treatment Market Share by Region (2020-2031)
Figure 34. China Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Sepsis Treatment Market Share by Country (2020-2031)
Figure 42. Mexico Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Sepsis Treatment Market Share by Country (2020-2031)
Figure 46. Turkey Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Sepsis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Pfizer Revenue Growth Rate in Sepsis Treatment Business (2020-2025)
Figure 50. NCPC Revenue Growth Rate in Sepsis Treatment Business (2020-2025)
Figure 51. Bayer Revenue Growth Rate in Sepsis Treatment Business (2020-2025)
Figure 52. Shanghai Pharmaceuticals Revenue Growth Rate in Sepsis Treatment Business (2020-2025)
Figure 53. Johnson & Johnson Revenue Growth Rate in Sepsis Treatment Business (2020-2025)
Figure 54. Novartis Revenue Growth Rate in Sepsis Treatment Business (2020-2025)
Figure 55. GlaxoSmithKline Revenue Growth Rate in Sepsis Treatment Business (2020-2025)
Figure 56. TEVA Revenue Growth Rate in Sepsis Treatment Business (2020-2025)
Figure 57. Mylan Revenue Growth Rate in Sepsis Treatment Business (2020-2025)
Figure 58. Allergan Revenue Growth Rate in Sepsis Treatment Business (2020-2025)
Figure 59. Merck & Co Revenue Growth Rate in Sepsis Treatment Business (2020-2025)
Figure 60. Asahi Kasei Corporation Revenue Growth Rate in Sepsis Treatment Business (2020-2025)
Figure 61. AtoxBio Revenue Growth Rate in Sepsis Treatment Business (2020-2025)
Figure 62. INOTREM Revenue Growth Rate in Sepsis Treatment Business (2020-2025)
Figure 63. Adrenomed Revenue Growth Rate in Sepsis Treatment Business (2020-2025)
Figure 64. Endacea Revenue Growth Rate in Sepsis Treatment Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
